In the PD context, it was observed that the CB1 protects nigrostriatal dopaminergic neurons against MPTP neurotoxicity in mouse, by preventing microglia-derived oxidative damage, suggesting a close relationship between the cannabinoid system and neuroinflammatory events [45]. Here, CNR1 is linked to Parkinson disease.